Pfizer

Pfizer Net Change in Cash

The Net Change in Cash of Pfizer (PFIZER.NS) as of Nov 12, 2026 is 25.97 B INR. In the previous year, Net Change in Cash was 3.83 B INR — a change of 578.03% (higher).

Net Change in Cash

25.97 BINR

YoY

578.03%

Last updated:

Net Change in Cash of Pfizer is 2026 25.97 B INR. Net Change in Cash of Pfizer was 2025 3.83 B INR. It decreases by 578.03% higher compared to the previous year.

The Pfizer Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2019
230.80 M INR
Jan 1, 2020
16.90 B INR
Jan 1, 2021
-16.13 B INR
Jan 1, 2022
-884.50 M INR
Jan 1, 2023
-261.60 M INR
Jan 1, 2024
754.00 M INR
Jan 1, 2025
3.83 B INR
Jan 1, 2026
25.97 B INR
The Pfizer Net Change in Cash history
YEARNet Change in CashYoY
25.97 BINR+578.03%
3.83 BINR+408.05%
754.00 MINR-388.23%
-261.60 MINR-70.42%
-884.50 MINR-94.52%
-16.13 BINR-195.42%
16.90 BINR+7,222.27%
230.80 MINR-236.89%
-168.60 MINR+386.27%
-34.67 MINR-99.17%
-4.17 BINR-238.42%
3.02 BINR-126.80%
-11.25 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pfizer Stock analysis

What does Pfizer do? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pfizer stock

Net Change in Cash of Pfizer is 25.97 B INR in 2026.

Net Change in Cash of Pfizer changed from 3.83 B INR to 25.97 B INR, representing a 578.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Pfizer since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Pfizer historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Pfizer

All Key Metrics — Pfizer